Similarly, the MA.3914 and T-REX12 trials investigated the need for regional lymph node radiotherapy in patients with one or two macro-SLNMs; however, these trials were limited to patients with ER-positive, HER2-negative breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.